BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 20655381)

  • 1. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.
    Kono S; Yoshida K; Tomosugi N; Terada T; Hamaya Y; Kanaoka S; Miyajima H
    Biochim Biophys Acta; 2010 Nov; 1802(11):968-75. PubMed ID: 20655381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
    Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
    Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.
    De Domenico I; Ward DM; di Patti MC; Jeong SY; David S; Musci G; Kaplan J
    EMBO J; 2007 Jun; 26(12):2823-31. PubMed ID: 17541408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional iron deficiency in toxic milk mutant mice (tx-J) despite high hepatic ferroportin: a critical role of decreased GPI-ceruloplasmin expression in liver macrophages.
    Jończy A; Lipiński P; Ogórek M; Starzyński RR; Krzysztofik D; Bednarz A; Krzeptowski W; Szudzik M; Haberkiewicz O; Miłoń A; Grzmil P; Lenartowicz M
    Metallomics; 2019 Jun; 11(6):1079-1092. PubMed ID: 31011744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.
    Qiao B; Sugianto P; Fung E; Del-Castillo-Rueda A; Moran-Jimenez MJ; Ganz T; Nemeth E
    Cell Metab; 2012 Jun; 15(6):918-24. PubMed ID: 22682227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin and ferroportin: the new players in iron metabolism.
    De Domenico I; Ward DM; Kaplan J
    Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin targets ferroportin for degradation in hepatocytes.
    Ramey G; Deschemin JC; Durel B; Canonne-Hergaux F; Nicolas G; Vaulont S
    Haematologica; 2010 Mar; 95(3):501-4. PubMed ID: 19773263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
    J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.
    De Domenico I; Lo E; Ward DM; Kaplan J
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3800-5. PubMed ID: 19234114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia.
    di Patti MC; Maio N; Rizzo G; De Francesco G; Persichini T; Colasanti M; Polticelli F; Musci G
    J Biol Chem; 2009 Feb; 284(7):4545-54. PubMed ID: 19095659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput screening of small molecules identifies hepcidin antagonists.
    Fung E; Sugianto P; Hsu J; Damoiseaux R; Ganz T; Nemeth E
    Mol Pharmacol; 2013 Mar; 83(3):681-90. PubMed ID: 23292796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron-regulatory gene expression during liver regeneration.
    Mollbrink A; Holmström P; Sjöström M; Hultcrantz R; Eriksson LC; Stål P
    Scand J Gastroenterol; 2012 May; 47(5):591-600. PubMed ID: 22364558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study.
    Nemeth E; Preza GC; Jung CL; Kaplan J; Waring AJ; Ganz T
    Blood; 2006 Jan; 107(1):328-33. PubMed ID: 16141345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface.
    Marques L; Auriac A; Willemetz A; Banha J; Silva B; Canonne-Hergaux F; Costa L
    Blood Cells Mol Dis; 2012 Feb; 48(2):110-20. PubMed ID: 22178061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient oxidative folding and site-specific labeling of human hepcidin to study its interaction with receptor ferroportin.
    Luo X; Jiang Q; Song G; Liu YL; Xu ZG; Guo ZY
    FEBS J; 2012 Sep; 279(17):3166-75. PubMed ID: 22776295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.